4D Pharma teams up with Parkinson’s UK
It is setting up a patient advisory board with the non-profit group made up of people living with the disease that will provide a “valuable patient-centric perspective” on a potential treatment Actor Michael J Fox lives with the debilitating disease
4D Pharma PLC (LON:DDDD; NASDAQ:LBPS) said it will collaborate with Parkinson’s UK as it continues to advance a drug that treats neurodegenerative conditions such as Parkinson s into clinical trials.
It is setting up a patient advisory board (PAB) with the non-profit group made up of people living with the disease that will provide a “valuable patient-centric perspective” on the potential treatment.
LZAGF Stock Price, Lonza Group Stock Quotes and News benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.
The Factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving the growth of this market. However, the high instrument costs especially that of dPCR and the technical limitations of PCR have restricted their greater use.
qPCR reagents and consumables accounted for the largest share of qPCR market
Based on products & services, the market is categorized into reagents and consumables, instruments and software & services. The qPCR reagents and consumables segment is expected to command the largest share of the qPCR products & services market in 2020, owing to the factors such as the expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing privat
Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $7.6 billion by 2025 - Exclusive Report by MarketsandMarkets Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospitals & Diagnostic Centers, Pharma Biotech, CROs) - Global Forecast to 2025 , published by MarketsandMarkets, the dPCR and qPCR market is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0% between 2020 and 2025.
Browse in-depth TOC on
253 - Tables
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204
The Factors such as the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project are driving